08:00 , Feb 20, 2012 |  BC Week In Review  |  Company News

Nanologica infectious, drug delivery news

Materials development company Nanologica joined the ORCHID alliance to improve the formulation and solubility of water-insoluble compounds to treat tuberculosis. The company will use its silica-based porous carrier materials to control the release of active...
07:00 , Sep 8, 2008 |  BioCentury  |  Strategy

Getting real at TB alliance

The not-for-profit world may focus on diseases ignored by the corporate world, but the problem is that they rarely actually get any drugs through development. The reasons cited by successful drug developers include lack of...